Patents by Inventor Harvey Masonson

Harvey Masonson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160264969
    Abstract: This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.
    Type: Application
    Filed: October 20, 2015
    Publication date: September 15, 2016
    Inventors: Samir Patel, Harvey Masonson
  • Publication number: 20150017163
    Abstract: The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
    Type: Application
    Filed: July 11, 2014
    Publication date: January 15, 2015
    Inventors: Samir Patel, Harvey Masonson, David Guyer
  • Publication number: 20140179621
    Abstract: This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.
    Type: Application
    Filed: August 9, 2013
    Publication date: June 26, 2014
    Applicant: Ophthotech Corporation
    Inventors: Samir Patel, Harvey Masonson
  • Publication number: 20120100136
    Abstract: This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.
    Type: Application
    Filed: October 28, 2011
    Publication date: April 26, 2012
    Applicant: OPHTHOTECH CORPORATION
    Inventors: Samir PATEL, Harvey Masonson